Search

Your search keyword '"4Is"' showing total 6 results
Start Over Descriptor "4Is"
6 results on '"4Is"'

2. Discussing the Application of 4Is Principle Under the Context of China—with Perfect Diary as an Example

Author

Cai, Xiaoqi, Striełkowski, Wadim, Editor-in-Chief, Black, Jessica M., Series Editor, Butterfield, Stephen A., Series Editor, Chang, Chi-Cheng, Series Editor, Cheng, Jiuqing, Series Editor, Dumanig, Francisco Perlas, Series Editor, Al-Mabuk, Radhi, Series Editor, Scheper-Hughes, Nancy, Series Editor, Urban, Mathias, Series Editor, Webb, Stephen, Series Editor, Ali, Ghaffar, editor, Birkök, Mehmet Cüneyt, editor, and Khan, Intakhab Alam, editor

Published
2022
Full Text
View/download PDF

3. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM.

Author

Slart, Riemer H. J. A., Glaudemans, Andor W. J. M., Gheysens, Olivier, Lubberink, Mark, Kero, Tanja, Dweck, Marc R., Habib, Gilbert, Gaemperli, Oliver, Saraste, Antti, Gimelli, Alessia, Georgoulias, Panagiotis, Verberne, Hein J., Bucerius, Jan, Rischpler, Christoph, Hyafil, Fabien, and Erba, Paola A.

Subjects
*COMPUTED tomography, *CARDIOGRAPHIC tomography, *CARDIOVASCULAR diseases, *JOINT diseases, *INNERVATION, *STANDARDIZATION
Abstract

With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is). This standard should be applied in clinical practice and integrated in clinical (multicenter) trials for optimal procedural standardization. A major focus is put on procedures using [18F]FDG, but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicenter trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Finally, PET/MR applications in 4Is cardiovascular diseases are also briefly described. Diagnosis and management of 4Is-related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/MR, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

4. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary

Author

Alessia Gimelli, Christoph Rischpler, Panagiotis Georgoulias, Hein J. Verberne, Gilbert Habib, Andor W. J. M. Glaudemans, Jan Bucerius, Marc R. Dweck, Fabien Hyafil, Paola Anna Erba, Riemer H. J. A. Slart, Mark Lubberink, Olivier Gheysens, Antti Saraste, Tanja Kero, Oliver Gaemperli, Slart, R, Glaudemans, A, Gheysens, O, Lubberink, M, Kero, T, Dweck, M, Habib, G, Gaemperli, O, Saraste, A, Gimelli, A, Georgoulias, P, Verberne, H, Bucerius, J, Rischpler, C, Hyafil, F, Erba, P, University Medical Center Groningen [Groningen] (UMCG), Cliniques Universitaires Saint-Luc [Bruxelles], Uppsala University, University of Edinburgh, Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille), Hirslanden Medical Center, Department of Radiology, Turku PET Center, Turku University Hospital, University of Turku, Fondazione Toscana Gabriele Monasterio, Univ Hosp Larissa, Department of Radiology and Nuclear Medicine [Amsterdam], VU University Medical Center [Amsterdam], University Medical Center Göttingen (UMG), University of Duisburg-Essen, CIC - CHU Bichat, Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, University of Pisa - Università di Pisa, Univ Groningen, COMBE, Isabelle, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord, Universität Duisburg-Essen = University of Duisburg-Essen [Essen], ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Translational Immunology Groningen (TRIGR), Cardiovascular Centre (CVC), UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, and UCL - (SLuc) Service de médecine nucléaire

Subjects
medicine.medical_specialty, Standardization, [SDV]Life Sciences [q-bio], Medizin, Joined procedurals, Computed tomography, 030204 cardiovascular system & hematology, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Eacvi/Eanm Recommendation, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Medical imaging, medicine, Humans, AcademicSubjects/MED00200, Radiology, Nuclear Medicine and imaging, Cardiac PET/CT • Joined procedurals • 4Is • cardiovascular diseases, 4I, medicine.diagnostic_test, business.industry, Magnetic resonance imaging, General Medicine, Reference Standards, Cardiovascular disease, 3. Good health, [SDV] Life Sciences [q-bio], Clinical trial, 4Is, Cardiovascular diseases, Joined procedural, Cardiovascular Diseases, Cardiac PET, Positron emission tomography, Positron-Emission Tomography, Radiology, Radiopharmaceuticals, Ct imaging, Cardiac PET/CT, Cardiology and Cardiovascular Medicine, business
Abstract

With this summarized document we share the standard for positron emission tomography (PET)/(diagnostic)computed tomography (CT) imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is) as recently published in the European Journal of Nuclear Medicine and Molecular Imaging. This standard should be applied in clinical practice and integrated in clinical (multicentre) trials for optimal standardization of the procedurals and interpretations. A major focus is put on procedures using [18F]-2-fluoro-2-deoxyglucose ([18F]FDG), but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this summarized document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicentre trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Diagnosis and management of 4Is related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/magnetic resonance, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.

Published
2021

5. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM

Author

Riemer H. J. A. Slart, Hein J. Verberne, Andor W. J. M. Glaudemans, Alessia Gimelli, Jan Bucerius, Gilbert Habib, Tanja Kero, Mark Lubberink, Paola Anna Erba, Panagiotis Georgoulias, Antti Saraste, Christoph Rischpler, Fabien Hyafil, Oliver Gaemperli, Olivier Gheysens, Marc R. Dweck, Radiology and Nuclear Medicine, ACS - Amsterdam Cardiovascular Sciences, University Medical Center Groningen [Groningen] (UMCG), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Département de Cardiologie [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), University of Pisa - Università di Pisa, Slart, R, Glaudemans, A, Gheysens, O, Lubberink, M, Kero, T, Dweck, M, Habib, G, Gaemperli, O, Saraste, A, Gimelli, A, Georgoulias, P, Verberne, H, Bucerius, J, Rischpler, C, Hyafil, F, Erba, P, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de médecine nucléaire, UCL - (SLuc) Centre du cancer, ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Translational Immunology Groningen (TRIGR), and Cardiovascular Centre (CVC)

Subjects
medicine.medical_specialty, Standardization, PET/CT, Medizin, Procedural recommendations, Guidelines, 030204 cardiovascular system & hematology, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Fluorodeoxyglucose F18, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Positron Emission Tomography Computed Tomography, medicine, Humans, [SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology, Radiology, Nuclear Medicine and imaging, 4I, Clinical care, Procedural recommendation, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, PET-CT, business.industry, 4Is, Cardiovascular diseases, General Medicine, Reference Standards, Cardiovascular disease, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, 3. Good health, Clinical trial, Clinical Practice, Cardiac PET, Positron-Emission Tomography, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Radiologi och bildbehandling, Radiology, Radiopharmaceuticals, Ct imaging, Tomography, X-Ray Computed, business, Radiology, Nuclear Medicine and Medical Imaging
Abstract

With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is). This standard should be applied in clinical practice and integrated in clinical (multicenter) trials for optimal procedural standardization. A major focus is put on procedures using [18F]FDG, but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicenter trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Finally, PET/MR applications in 4Is cardiovascular diseases are also briefly described. Diagnosis and management of 4Is-related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/MR, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.

Published
2020

6. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM.

Author

UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de médecine nucléaire, UCL - (SLuc) Centre du cancer, Slart, Riemer H J A, Glaudemans, Andor W J M, Gheysens, Olivier, Lubberink, Mark, Kero, Tanja, Dweck, Marc R, Habib, Gilbert, Gaemperli, Oliver, Saraste, Antti, Gimelli, Alessia, Georgoulias, Panagiotis, Verberne, Hein J, Bucerius, Jan, Rischpler, Christoph, Hyafil, Fabien, Erba, Paola A, 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI), European Association of Nuclear Medicine (EANM), UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de médecine nucléaire, UCL - (SLuc) Centre du cancer, Slart, Riemer H J A, Glaudemans, Andor W J M, Gheysens, Olivier, Lubberink, Mark, Kero, Tanja, Dweck, Marc R, Habib, Gilbert, Gaemperli, Oliver, Saraste, Antti, Gimelli, Alessia, Georgoulias, Panagiotis, Verberne, Hein J, Bucerius, Jan, Rischpler, Christoph, Hyafil, Fabien, Erba, Paola A, 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI), and European Association of Nuclear Medicine (EANM)

Abstract

With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is). This standard should be applied in clinical practice and integrated in clinical (multicenter) trials for optimal procedural standardization. A major focus is put on procedures using [F]FDG, but 4Is PET radiopharmaceuticals beyond [F]FDG are also described in this document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicenter trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Finally, PET/MR applications in 4Is cardiovascular diseases are also briefly described. Diagnosis and management of 4Is-related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/MR, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results